Westport, Conn., USA - October 20, 2009, Westport, Conn., USA - Advanced BioHealing, a biotechnology company, announced four key promotions within the company's executive management team.
Article continues below
Theresa Dixon has been promoted to Vice President of Government Affairs & Health Economics, where she is responsible for leading the Company's government affairs, health policy and health economics initiatives. Since joining ABH in January 2007, Ms. Dixon has spearheaded the development of the Company's industry-leading reimbursement and government affairs team.
In her new role, Ms. Dixon is charged with continuing to build ABH's government relations capabilities while also developing organizational expertise in health outcomes and comparative effectiveness.
Ms. Dixon is a 15-year veteran of the biotechnology industry and has held Health Economics responsibilities for Smith & Nephew and Covance Health Economics & Outcomes Services (previously Corning Inc.).
Kathy McGee, who joined the Company in May 2006 when ABH purchased Dermagraft and TransCyte from Smith and Nephew Wound Management LLC, has been promoted to Vice President and General Manager (La Jolla facility). Ms. McGee has been involved with these products for over 17 years and is a globally recognized expert in the manufacture and distribution of cell-based products.
Previously, Ms. McGee served as Director of Manufacturing Operations at Smith & Nephew, and was instrumental in renovating and revalidating ABH's manufacturing facility.
Prior to joining Smith & Nephew, Ms. McGee held several positions in Manufacturing and Quality Control at Advanced Tissue Sciences.
Keith O'Briant, formerly ABH's Vice President of Sales, has been named the Company's new Senior Vice President of North American Sales.
Mr. O'Briant, who built the Company's sales force to over 80 professionals in nine regional teams during the past three years, is now responsible for accelerating the recruitment and training of a North American sales team that will include over 100 professionals by year-end 2009. A veteran of healthcare commercialization, Mr. O'Briant held a variety of commercial and sales leadership positions within Pfizer.
Dean Tozer, responsible for creating ABH's initial commercialization strategy, has been promoted to Senior Vice President. In this position, he will oversee ABH's marketing, corporate development, reimbursement, government affairs and product development. ■